NIH review cites scientists for breaking ethics rules on drug ties

A review by the NIH has concluded that 44 government scientists have violated ethics rules with their ties to pharmaceutical companies, and nine of them may have broken the law. The 44 scientists had either failed to disclose payments from drug companies, failed to get the NIH's permission to consult with them or did work for the drug companies on government time. Congressman Joe Barton said the ethical problems were "more systemic and severe than previously known."

- read this story from The New York Times for more

Suggested Articles

The public financing will enable Monopar to start a phase 3 trial of a prophylactic treatment for a side effect of chemoradiotherapy. 

The dispute centers on whether Asa Abeliovich used Alector’s confidential information in connection with his work for Prevail Therapeutics.

GSK poaches Merck KGaA's Martinez-Davis to helm pharma stateside; Bulto named Novartis U.S. pharma head; Allergan's Saunders set for huge parachute.